Saturday, February 14, 2026 2/14/2026

DC Department of Health Care Finance CGT Access Model

Award Number: 2P2CMS332033
ORGANIZATION: HEALTH CARE FINANCING ADMINISTRATION, OFFICE OF ACQUISITION AND GRANTS
OPDIV: CMS
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: OTHER
PERIOD OF PERFORMANCE START DATE: 08/01/2025
PERIOD OF PERFORMANCE END DATE: 12/31/2035

Group Awards By:

View Award Description

DC Department of Health Care Finance CGT Access Model - The District of Columbia State Medicaid Agency, The Department of Health Care Finance (DHCF), seeks funding through opportunity number CMS-2P2-25-001 “Cell and Gene Therapy (CGT) Access Model” to support District implementation of the CGT Access Model and improve and access to cell and gene therapy for sickle cell disease patients, and support their care journey and outcomes. CMS introduced the CGT access model in 2023, which tests the question of whether CMS negotiated outcomes based agreements will allow facilitate reduced prices and increased outcomes for individuals with sickle cell disease. In recognition of the burden of required implementation activities and the opportunity to support increased access and improved outcomes for individuals on therapy, CMS has provided this grant opportunity in conjunction with the model test. The CMMI grant funds will support DHCF in: 1. Building the internal agency capacity to participate fully in the CGT access model and meet all participation requirements fully. 2. Providing direct support for patients and their families as they engage in the care delivery journey for new groundbreaking therapies for sickle cell disease; and 3. Increase community awareness and engagement across the sickle cell disease community and providers to support increased access to cell and gene therapy and improvement across the care journey The District is requesting $7,072,261 over the ten (10) year performance period of the grant. The funding be used to add a staff position, support model implementation activities, and provide direct support to individuals eligible for sickle cell disease gene therapy. This support will allow the District to achieve the above-mentioned goals, participate in the national model test, and ultimately improve outcomes for sickle cell disease patients and their families in the District.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $630,640 )
2026	2026	DEPARTMENT OF HEALTH CARE FINANCE	441 4TH ST NW STE 900S	WASHINGTON	DC	20001	DISTRICT OF COLUMBIA	USA	Cell and Gene Therapy (CGT) Access Model	02	1	2/12/2026	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2026	DEPARTMENT OF HEALTH CARE FINANCE	441 4TH ST NW STE 900S	WASHINGTON	DC	20001	DISTRICT OF COLUMBIA	USA	Cell and Gene Therapy (CGT) Access Model	01	1	11/20/2025	SUPPLEMENT FOR EXPANSION	$630,640
														Subtotal = $630,640

Issue Date FY: 2025 ( Subtotal = $565,398 )
2025	2025	DEPARTMENT OF HEALTH CARE FINANCE	441 4TH ST NW STE 900S	WASHINGTON	DC	20001	DISTRICT OF COLUMBIA	USA	Cell and Gene Therapy (CGT) Access Model	00	1	8/1/2025	NEW	$565,398
														Subtotal = $565,398

Grand Total All Awards = $1,196,038

Top

All Categories

About

Search

Reports

Data Submission

Award Information

DC Department of Health Care Finance CGT Access Model

Award Number: 2P2CMS332033

ORGANIZATION: HEALTH CARE FINANCING ADMINISTRATION, OFFICE OF ACQUISITION AND GRANTS

OPDIV: CMS

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: OTHER

PERIOD OF PERFORMANCE START DATE: 08/01/2025

PERIOD OF PERFORMANCE END DATE: 12/31/2035

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer